WELLS FARGO & COMPANY/MN - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,813,283
-29.1%
88,109
+61.9%
0.00%0.0%
Q2 2023$2,559,252
+19.0%
54,429
+6.2%
0.00%0.0%
Q1 2023$2,149,821
+479.7%
51,235
+426.9%
0.00%
Q4 2022$370,836
-23.5%
9,723
-21.5%
0.00%
Q3 2022$485,000
+484.3%
12,387
+381.6%
0.00%
Q2 2022$83,000
+59.6%
2,572
+65.7%
0.00%
Q1 2022$52,000
-1.9%
1,552
+24.6%
0.00%
Q4 2021$53,000
-98.4%
1,246
-98.3%
0.00%
-100.0%
Q3 2021$3,294,000
-53.4%
74,343
-40.2%
0.00%
-50.0%
Q2 2021$7,063,000
-9.5%
124,336
+19.2%
0.00%0.0%
Q1 2021$7,808,000
-14.6%
104,316
-1.4%
0.00%0.0%
Q4 2020$9,148,000
-2.9%
105,757
-68.3%
0.00%0.0%
Q3 2020$9,420,000
+62.8%
334,065
+33.9%
0.00%0.0%
Q2 2020$5,788,000
+74.5%
249,476
+116.1%
0.00%
+100.0%
Q1 2020$3,316,000
-41.9%
115,462
+38.4%
0.00%
-50.0%
Q4 2019$5,705,000
-90.8%
83,450
-81.0%
0.00%
-88.2%
Q3 2019$61,726,000
-14.1%
439,990
+10.4%
0.02%
-19.0%
Q2 2019$71,842,000
+21.6%
398,460
+7.3%
0.02%
+16.7%
Q1 2019$59,057,000
+98.2%
371,305
+19.4%
0.02%
+80.0%
Q4 2018$29,800,000
-45.7%
311,101
-20.0%
0.01%
-37.5%
Q3 2018$54,905,000
+25.5%
388,706
+39.1%
0.02%
+23.1%
Q2 2018$43,743,000
+62.8%
279,456
+58.9%
0.01%
+62.5%
Q1 2018$26,870,000
+422.5%
175,894
+463.3%
0.01%
+700.0%
Q4 2017$5,143,000
-20.6%
31,225
-70.0%
0.00%
-50.0%
Q3 2017$6,480,000
+8.9%
104,016
+39.2%
0.00%0.0%
Q2 2017$5,951,000
+149.4%
74,723
+122.6%
0.00%
+100.0%
Q1 2017$2,386,000
+24.7%
33,575
-10.4%
0.00%0.0%
Q4 2016$1,913,000
+94.8%
37,464
+75.6%
0.00%
Q3 2016$982,000
+19.5%
21,339
-21.7%
0.00%
Q2 2016$822,000
+1.0%
27,266
+7.4%
0.00%
Q1 2016$814,000
-43.7%
25,392
+2.4%
0.00%
-100.0%
Q4 2015$1,446,000
+123.8%
24,804
+62.6%
0.00%
Q3 2015$646,000
-37.6%
15,256
+7.6%
0.00%
Q2 2015$1,035,000
+531.1%
14,177
+335.1%
0.00%
Q1 2015$164,000
+1540.0%
3,258
+1120.2%
0.00%
Q4 2014$10,0002670.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders